Descrizione del principio attivo Il semaglutide un agonista del recettore GLP-1 impiegato nel trattamento del diabete di tipo 2 e nella gestione del peso corporeo
Collagen is produced with each treatment, resulting in significant rejuvenation over time
The potential protective effects of semaglutide on mental health could be due to weight loss, a decrease in food noise, some combination of the two, or an entirely different mechanism, perhaps related to GLP-1's direct effects on the brain, says Anna Lembke, MD, a psychiatry professor at Stanford Medicine in California
The medication works by mimicking the incretin hormone GLP-1, which enhances insulin secretion, suppresses glucagon release, slows gastric emptying (though this effect may attenuate over time), and reduces appetite through central nervous system pathways
Stress, sleep, insulin resistance, and age can all matter too